Our randomized crossover trial of nicotinamide riboside (NR) and co-enzyme Q10 (CoQ10) in sedentary patients with chronic kidney disease (CKD) is now published in CJASN.
Read the full article:https://journals.lww.com/cjasn/abstract/9900/a_pilot_trial_of_nicotinamide_riboside_and.533.aspx#
10 months ago